Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 42,005 | -384,632 | -52,556 | 8,201 | -4 |
| Depreciation Amortization | 97 | 99 | 68 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,522 | -4,590 | 6,613 | N/A | N/A |
| Other Working Capital | 706 | -2,739 | 6,268 | 441 | 4 |
| Other Operating Activity | -65,622 | 344,037 | 4,023 | -10,137 | 0 |
| Operating Cash Flow | $-20,292 | $-47,825 | $-35,584 | $-1,495 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -306 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -276,000 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-306 | $-276,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 14,000 | 44,500 | 35 | N/A |
| Debt Repayment | N/A | N/A | -3,992 | -74 | N/A |
| Common Stock Issued | 147 | N/A | N/A | 278,300 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -269 | 0 |
| Financing Cash Flow | $15,147 | $14,000 | $40,508 | $277,992 | $N/A |
| Beginning Cash Position | 5,158 | 40,984 | 5,128 | N/A | N/A |
| End Cash Position | 13 | 7,159 | 9,746 | 497 | N/A |
| Net Cash Flow | $-5,145 | $-33,825 | $4,618 | $497 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,292 | -47,825 | -35,584 | -1,495 | N/A |
| Capital Expenditure | N/A | N/A | -306 | N/A | N/A |
| Free Cash Flow | -20,292 | -47,825 | -35,890 | -1,495 | 0 |